SINGAPORE/BEIJING Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday. | Video
SINGAPORE/BEIJING Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
SAO PAULO/BEIJING Brazil's health regulator suspended a clinical trial of China's Sinovac coronavirus vaccine due to a severe adverse event, delighting President Jair Bolsonaro, who has repeatedly criticized the vaccine's credibility and said it would not be purchased by his government.
SAO PAULO/BEIJING Brazil's health regulator has suspended a clinical trial for China's Sinovac coronavirus vaccine citing a severe adverse event, delighting President Jair Bolsonaro, who has criticized it for lacking credibility amid growing geopolitical tensions as the global race for a COVID-19 vaccine continues.
BEIJING/SAO PAULO An experimental coronavirus vaccine developed by China's Sinovac Biotech appeared to be safe in a late-stage clinical trial in Brazil, preliminary results showed on Monday.
BEIJING About 90% of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country's emergency use programme, its chief executive said on Sunday.
WASHINGTON/BEIJING Top U.S. and Chinese trade officials reaffirmed their commitment to a Phase 1 trade deal, which has seen China lagging on its obligations to buy American goods, giving a boost to financial markets on Tuesday.
A man identifying himself as the leader of Nigeria's Boko Haram said on Tuesday the Islamist group was behind the abduction of more than 300 schoolboys, as anxious parents begged the government to secure their release.